SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026)
SS Innovations International recorded quarterly Cash from Investing Activities of -$54189.0 in Q1 2026, up 96.84% quarter-over-quarter from -$1.7 million in Q4 2025, and up 93.79% year-over-year from -$27962.5 in Q1 2025.
SS Innovations International's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$54189.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 93.79% year-over-year to -$54189.0; the TTM figure through Mar 2026 stood at -$2.8 million (down 101.88% YoY), while the FY2025 annual figure was -$3.7 million, down 453.16% from the prior year.
- Cash from Investing Activities came in at -$54189.0 for Q1 2026 at SS Innovations International, up from -$1.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q3 2024 to a low of -$2.1 million in Q2 2024.
- A 5-year average of -$331267.5 and a median of -$127255.0 in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities slumped 6329.8% in 2023 and surged 872.1% in 2024, its largest moves.
- SS Innovations International's Cash from Investing Activities stood at -$137530.0 in 2022, then gained by 7.48% to -$127249.0 in 2023, then grew by 1.66% to -$125142.0 in 2024, then tumbled by 1270.07% to -$1.7 million in 2025, then surged by 96.84% to -$54189.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$54189.0, -$1.7 million, and -$755075.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | -54,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54,189.00 |
| Mar 31, 2026 | -54,189.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -755,075.00 |
| Sep 30, 2025 | -755,075.00 |
| Jun 30, 2025 | -316,648.00 |
| Jun 30, 2025 | -316,648.00 |
| Mar 31, 2025 | -872,804.00 |
| Mar 31, 2025 | -872,804.00 |
| Dec 31, 2024 | -125,142.00 |
| Dec 31, 2024 | -125,142.00 |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -127,255.00 |
| Mar 31, 2024 | -127,255.00 |
| Dec 31, 2023 | -127,249.00 |
| Dec 31, 2023 | -127,249.00 |
| Sep 30, 2023 | -220,542.00 |
| Sep 30, 2023 | -220,542.00 |
| Jun 30, 2023 | -33,655.00 |
| Jun 30, 2023 | -33,655.00 |
| Mar 31, 2023 | -71,881.00 |
| Mar 31, 2023 | -71,881.00 |
| Dec 31, 2022 | -137,530.00 |
| Dec 31, 2022 | -137,530.00 |
| Sep 30, 2022 | -3,430.00 |
| Sep 30, 2022 | -3,430.00 |
| Dec 31, 2021 | 26,000.00 |
| Dec 31, 2021 | 26,000.00 |
| Dec 31, 2020 | -40,000.00 |
| Dec 31, 2020 | -40,000.00 |
| Mar 31, 2020 | -4,000.00 |
| Mar 31, 2020 | -4,000.00 |
| Dec 31, 2019 | 25,000.00 |
| Dec 31, 2019 | 25,000.00 |
| Sep 30, 2019 | -122.00 |
| Sep 30, 2019 | -122.00 |
| Sep 30, 2018 | -5,001.00 |
| Sep 30, 2018 | -5,001.00 |
| Jun 30, 2018 | -770.00 |
| Jun 30, 2018 | -770.00 |
| Mar 31, 2018 | -17,797.00 |
| Mar 31, 2018 | -17,797.00 |
| Mar 31, 2017 | -4,174.00 |
| Mar 31, 2017 | -4,174.00 |